The medical community is excited with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 receptor that’s demonstrating significant efficacy in clinical trials for managing obesity. Unlike some current weight loss treatments, retatrutide appears to provide a significant substantial reduction in body weight and improve metabolic heal… Read More